Literature DB >> 32095506

Kidney Donor Profile Index Is a Reliable Alternative to Liver Donor Risk Index in Quantifying Graft Quality in Liver Transplantation.

Uwe Scheuermann1, Tracy Truong2, Elisabeth R Seyferth1, Kyle Freischlag1, Qimeng Gao1, John Yerxa1, Brian Ezekian1, Robert P Davis1, Paul M Schroder1, Sarah B Peskoe2, Andrew S Barbas1.   

Abstract

BACKGROUND: The most established metric for estimating graft survival from donor characteristics in liver transplantation is the liver donor risk index (LDRI). The LDRI is calculated from donor and transplant-related variables, including cold ischemic time. Because cold ischemic time is unknown at the time of organ offer, LDRI is not available for organ acceptance decisions. In contrast, the kidney donor profile index (KDPI) is derived purely from donor variables known at the time of offer and thus calculated for every deceased donor in the United States. The similarity in donor factors included in LDRI and KDPI led us to hypothesize that KDPI would reliably approximate LDRI in estimating graft survival in liver transplantation.
METHODS: The United Network of Organ Sharing registry was queried for adults who underwent deceased donor liver transplantation from 2002 to 2016. The cohort was divided into quintiles of KDPI and LDRI, and graft survival was calculated according to Kaplan Meier. Hazard ratios for LDRI and KDPI were estimated from Cox proportional hazards models, and Uno's concordance statistic was compared.
RESULTS: In our analysis of 63 906 cases, KDPI closely approximated LDRI in estimating liver graft survival, with an equivalent concordance statistic of 0.56.
CONCLUSIONS: We conclude that KDPI can serve as a reasonable alternative to LDRI in liver acceptance decisions.
Copyright © 2019 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc.

Entities:  

Year:  2019        PMID: 32095506      PMCID: PMC7004589          DOI: 10.1097/TXD.0000000000000955

Source DB:  PubMed          Journal:  Transplant Direct        ISSN: 2373-8731


In the current era, the major obstacle facing the field of liver transplantation is the severe shortage of donor organs. In response to this shortage, transplant programs are increasingly evaluating and utilizing organs from extended criteria donors, including donors of advanced age, donors with hepatic steatosis, and donors after circulatory death.[1-5] As such, accurate estimation of donor risk in liver transplantation has never been more important. The most established metric for estimating graft survival from donor characteristics in liver transplantation is the liver donor risk index (LDRI), introduced by Fang et al[6] in 2006. Calculated from donor characteristics (age, race, height, cause of death, and donation after circulatory death [DCD] status) and transplant factors (local/regional/national share, and cold ischemic time [CIT]), the LDRI represents a hazard ratio for graft failure in reference to a standard reference donor. Although the LDRI has provided a valuable framework for quantifying graft quality, it is not available in real time for organ acceptance decisions due to its inclusion of CIT. In particular, LDRI is not presented in United Network of Organ Sharing (UNOS) Donor Net, the online platform used for donor evaluation and organ acceptance in the United States. In kidney transplantation, the kidney donor risk index (KDRI) was introduced by Rao et al[7] to estimate donor risk. In contrast to LDRI, the KDRI does not include CIT and is based purely on donor factors known at the time of organ offer (Table 1). To make the KDRI score easier to conceptualize, it is routinely transformed to a percentile score ranging from 0% to 100%, known as the kidney donor profile index (KDPI). With this transformation, the KDPI represents the percentile of quality of a particular donor relative to all kidney donors recovered during the previous year. In contrast to LDRI, the KDPI is routinely presented in UNOS Donor Net for every deceased donor at the time of organ offer.
TABLE 1.

Donor and transplant characteristics used in the calculation of KDPI and LDRI

Donor and transplant characteristics used in the calculation of KDPI and LDRI As demonstrated in Table 1, there is an overlap of several donor factors used in the calculation of LDRI and KDPI, including age, height, race, cause of death, and DCD status.[8] Due to this considerable similarity, we hypothesized that KDPI would serve as a reasonable alternative to LDRI in quantifying graft quality in liver transplantation. Thus, the primary aim of this study was to compare KDPI and LDRI in estimating liver graft survival in the United States in an era of Model of End-Stage Liver Disease (MELD)-based liver allocation. A secondary aim of the study was to determine how using an assumed CIT of 8 hours would impact the LDRI calculation, which has the potential to enhance the utility of LDRI in organ acceptance decisions.

MATERIALS AND METHODS

Data Source

The Duke University Institutional Review Board granted exempt status for this retrospective analysis of the UNOS/OPTN Standard Transplant Analysis Research file. KDPI scores were obtained directly from the database, and LDRI scores were calculated as described by Fang et al[6] when all data elements were available for analysis.

Study Design

All adult recipients (≥18 y of age) who underwent initial deceased donor liver transplantation between February 27, 2002, and March 31, 2016, were included in the analysis. The year 2002 was selected as the starting point for our analysis due to the introduction of MELD-based liver allocation in the United States. Patients undergoing multiorgan transplants, retransplants, and machine preservation of donor livers and those with missing data were excluded from the study.

Outcome

Graft survival was calculated as the time from initial transplant to graft failure, retransplant, or all-cause death. If a recipient was alive or lost to follow-up at time of last contact, then survival time was censored at time of last contact.

Statistical Analysis

Donor characteristics included in the calculation of LDRI were age, race, height, cause of death, DCD status, graft type (split versus whole), organ origin (local versus regional versus national share), and CIT. Because CIT is unknown at the time of organ offer, LDRI was calculated in 2 ways: (1) using the actual CIT and (2) using an assumed CIT of 8 hours. This comparison was made to determine whether using an assumed value of 8 hours for CIT would change the LDRI value substantially. If the 2 versions of LDRI closely agree, there would be rationale to calculate and present LDRI with an assumed CIT of 8 hours in UNOS DonorNet at the time of organ offer. KDPI was recorded for each donor. Data elements are summarized using mean and SD or frequency and percentage. LDRI takes on values ≥0 and KDPI ranges from 0 to 1. First, a scatterplot depicting KDPI and LDRI for each subject was generated to allow visualization of the relationship between the 2 scores, and linear correlation was estimated using Pearson’s correlation. To assess graft survival as a function of KDPI and LDRI, the study cohort was divided into quintiles for each index and Kaplan-Meier estimates were calculated. Uno’s concordance statistic,[9] as implemented by PROC PHREG, was computed to estimate the predictive ability of these indices in estimating donor risk. Concordance statistics range between 0 and 1 with values closer to 0.5 indicating poor concordance and values closer to 1 indicating strong concordance. Receiver operating characteristic (ROC) curves and area under the curve were approximated using a logistic regression model. P < 0.05 was regarded as significant. All analyses were performed in R version 3.5.0 (Vienna, Austria) and SAS 9.4 (SAS Institute Inc., Cary, NC).

RESULTS

Study Population

The final study population consisted of 63 906 patients who met inclusion criteria. We excluded 31 patients with no survival time, and 3737 cases with missing data needed to calculate either KDPI or LDRI. Baseline donor and transplant characteristics of the study are displayed in Table 2. The mean LDRI for the cohort was 1.4 (SD = 0.4), while the mean KDPI was 0.5 (SD = 0.3). A scatterplot demonstrating KDPI and LDRI for each subject in the study is shown in Figure 1. Pearson’s correlation coefficient is 0.74, indicating a strong correlation between KDPI and LDRI.
TABLE 2.

Donor and transplant characteristics of the study population

FIGURE 1.

Scatterplot demonstrating KDPI and LDRI for each study subject. A strong correlation is observed between the 2 scores, with a Pearson correlation coefficient of 0.74. KDPI, kidney donor profile index; LDRI, liver donor risk index.

Donor and transplant characteristics of the study population Scatterplot demonstrating KDPI and LDRI for each study subject. A strong correlation is observed between the 2 scores, with a Pearson correlation coefficient of 0.74. KDPI, kidney donor profile index; LDRI, liver donor risk index.

Comparison of Long-term Graft Survival by Quintiles of KDPI and LDRI

Graft survival for the entire cohort at 1, 5, and 10 was 87.2%, 76.2%, and 71.2%, respectively. Kaplan-Meier curves demonstrated that graft survival was strongly associated with quintile of donor quality for both KDPI and LDRI (Figure 2). One-, 5-, and 10-year graft survival was similar for KDPI and LDRI by quintile. For example, 1-year graft survival by quintile for KDPI versus LDRI was 90% versus 91% (quintile 1), 89% versus 89% (quintile 2), 87% versus 87% (quintile 3), 85% versus 85% (quintile 4), and 82% versus 82% (quintile 5).
FIGURE 2.

Graft survival as a function of KDPI and LDRI. Kaplan-Meier curves of graft survival by quintiles of (A) KDPI and (B) LDRI. Graft survival at 1, 5, and 10 years for quintiles of KDPI closely approximates graft survival for quintiles of LDRI. KDPI, kidney donor profile index; LDRI, liver donor risk index.

Graft survival as a function of KDPI and LDRI. Kaplan-Meier curves of graft survival by quintiles of (A) KDPI and (B) LDRI. Graft survival at 1, 5, and 10 years for quintiles of KDPI closely approximates graft survival for quintiles of LDRI. KDPI, kidney donor profile index; LDRI, liver donor risk index.

Hazard Ratios for Graft Failure by KDPI and LDRI

Hazard ratios for graft failure at 1, 5, and 10 years per 0.1 unit increase in KDPI and LDRI are shown in Table 3. For KDPI and both versions of LDRI (using actual CIT and imputing 8 h of CIT), each 0.1 unit increase in score was significantly associated with an increased risk of graft failure at 1, 5, and 10 years. There did not appear to be a substantial change in LDRI hazard ratios when imputing 8 hours of CIT in the formula instead of the actual CIT.
TABLE 3.

Hazard ratios and 95% confidence intervals for KDPI and LDRI for 1-, 5-, and 10-year graft failure

Hazard ratios and 95% confidence intervals for KDPI and LDRI for 1-, 5-, and 10-year graft failure

Concordance Statistics and ROC Curves

The ability of each score to discriminate between graft failure and survival was then analyzed by calculating the respective concordance statistics (c statistics), shown in Table 4. Due to the inclusion of only donor/transplant factors (and exclusion of recipient characteristics), both KDPI and LDRI demonstrate similarly modest c statistics (0.56–0.58) for graft survival at 1, 5, and 10 years. Again, using an imputed 8 hours of CIT for LDRI did not appear to change the c statistic substantially in comparison to actual LDRI.
TABLE 4.

Concordance statistics (SE) and AIC for KDPI and LDRI for 1-, 5-, and 10-year graft survival

Concordance statistics (SE) and AIC for KDPI and LDRI for 1-, 5-, and 10-year graft survival Uno’s statistic, which was used to calculate concordance while accounting for censoring, does not allow for direct generation of an ROC curve. For this reason, ROC curves were based on logistic regression for graft survival (Figure 3). The area under the curve was 0.56 for KDPI versus 0.57 for LDRI, indicating similar performance of both scores. It is noteworthy that these results were similar to the c statistics for graft survival presented in Table 4, which did account for censoring.
FIGURE 3.

ROC curves for KDPI and LDRI using logistic regression for graft survival. ROC curves for KDPI and LDRI overlap across the range of the respective index values, with an AUC of 0.56 for KDPI vs 0.57 for LDRI. AUC, area under the curve; KDPI, kidney donor profile index; LDRI, liver donor risk index; ROC, receiver operating characteristic.

ROC curves for KDPI and LDRI using logistic regression for graft survival. ROC curves for KDPI and LDRI overlap across the range of the respective index values, with an AUC of 0.56 for KDPI vs 0.57 for LDRI. AUC, area under the curve; KDPI, kidney donor profile index; LDRI, liver donor risk index; ROC, receiver operating characteristic.

DISCUSSION

The most established metric for estimating graft survival from donor characteristics in liver transplantation is the LDRI, introduced by Feng et al.[6] It has been validated in Europe[10] and has led to the development of both Eurotransplant-Donor Risk Index (ET-DRI) and United Kingdom (Donor Liver Index) counterparts.[11,12] At present, however, the utilization of LDRI in organ acceptance decisions is limited by its dependence on CIT, which is unknown at the time of organ offer. As such, LDRI is not presented in UNOS DonorNet, the online system for organ evaluation and allocation in the United States. In contrast, the KDPI is calculated from donor factors known at the time of organ offer and thus presented for every deceased donor on UNOS DonorNet. There are 2 primary findings in our analysis. First, we demonstrate that KDPI closely approximates LDRI in estimating graft survival in liver transplantation. Quintiles of KDPI and LDRI exhibit similar graft survival at 1, 5, and 10 years. Moreover, the models have identical overall c statistics. Second, we demonstrate that imputing an 8-hour CIT into the LDRI formula does not significantly change its predictive value. Adopting this methodology would allow the calculation of LDRI for all potential liver donors in UNOS DonorNet and may represent a practical solution to enhance the utility of LDRI in organ acceptance decision making. While KDPI appears to approximate LDRI very closely, it must be noted that neither metric appears to be particularly robust in prediction of liver graft survival, with c statistics in the 0.56–0.58 range. This observation is not surprising given that both KDPI and LDRI are based purely on donor factors and do not include any of the important recipient variables known to impact graft survival, including recipient age, MELD score, and patient acuity.[13-18] Other risk scoring systems have been introduced in liver transplantation that incorporate both donor and recipient factors, including D-MELD,[19] Survival outcomes following liver transplantation score,[15,17] and Balance of Risk score.[16] The c statistics for these scoring systems are higher at 0.6, 0.7, and 0.7, respectively, reflecting the important contribution of recipient factors in determining post-transplant outcomes.[16] Even so, c statistics in the 0.6–0.7 range are rather modest and highlight the difficulty of accurately predicting liver transplant outcomes based purely on clinical parameters. In general, there has not been widespread adoption of such scoring systems in day-to-day clinical practice. Barriers to greater utilization of the available scoring systems include the requirement for recipient chart review and subsequent calculation and interpretation of a numeric score, which present challenges when making organ acceptance decisions in the middle of the night. In clinical practice, organ acceptance decisions are made based on the judgment of transplant clinicians and include careful consideration of recipient status in parallel with donor and graft characteristics. Given the close overlap with LDRI, we believe KDPI can act as an immediately available surrogate to facilitate donor assessment. In light of the rising incidence of donor hepatic steatosis and its detrimental impact on graft survival, the inclusion of known risk factors (Diabetes Mellitus and Hypertension) in the KDPI may become more impactful in the future. That said, KDPI should certainly not be the only factor considered in organ acceptance. Inappropriate reliance on a particular clinical scoring system may have unintended consequences with regard to increased organ discard, as has been demonstrated for high KDPI kidneys.[20] There are some notable limitations of this study that should be mentioned, related to data source and study design. Due to missing data (either survival data or parameters needed to calculate KDPI or LDRI), we excluded a small percentage (5.5%) of all eligible patients. Even though the potential for bias in the final study population is minimal, it cannot be excluded entirely. In addition, the KDPI is calculated in reference to the pool of donors recovered in the previous calendar year. As such, there may be some amount of variation year to year with changes in the demographics of the donor population. In conclusion, estimating donor quality in liver transplantation remains a critical issue, particularly as the organ shortage forces transplant programs to increase consideration of extended criteria donors. KDPI appears to be an acceptable alternative to LDRI that is readily available at the time of organ offer and maybe a practical tool to use in organ acceptance decisions.
  20 in total

Review 1.  Development of organ-specific donor risk indices.

Authors:  Sanjeev K Akkina; Sumeet K Asrani; Yi Peng; Peter Stock; W Ray Kim; Ajay K Israni
Journal:  Liver Transpl       Date:  2012-04       Impact factor: 5.799

2.  Validation of the donor risk index in orthotopic liver transplantation within the Eurotransplant region.

Authors:  Joris J Blok; Andries E Braat; Rene Adam; Andrew K Burroughs; Hein Putter; Nigel G Kooreman; Axel O Rahmel; Robert J Porte; Xavier Rogiers; Jan Ringers
Journal:  Liver Transpl       Date:  2012-01       Impact factor: 5.799

3.  On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data.

Authors:  Hajime Uno; Tianxi Cai; Michael J Pencina; Ralph B D'Agostino; L J Wei
Journal:  Stat Med       Date:  2011-01-13       Impact factor: 2.373

4.  Safety and Outcomes in 100 Consecutive Donation After Circulatory Death Liver Transplants Using a Protocol That Includes Thrombolytic Therapy.

Authors:  H Bohorquez; J B Seal; A J Cohen; A Kressel; E Bugeaud; D S Bruce; I C Carmody; T W Reichman; N Battula; M Alsaggaf; G Therapondos; N Bzowej; G Tyson; S Joshi; R Nicolau-Raducu; N Girgrah; G E Loss
Journal:  Am J Transplant       Date:  2017-04-11       Impact factor: 8.086

5.  The Eurotransplant donor risk index in liver transplantation: ET-DRI.

Authors:  A E Braat; J J Blok; H Putter; R Adam; A K Burroughs; A O Rahmel; R J Porte; X Rogiers; J Ringers
Journal:  Am J Transplant       Date:  2012-07-23       Impact factor: 8.086

6.  Factors Associated With Short- and Long-term Liver Graft Survival in the United Kingdom: Development of a UK Donor Liver Index.

Authors:  David Collett; Peter J Friend; Christopher J E Watson
Journal:  Transplantation       Date:  2017-04       Impact factor: 4.939

7.  Characteristics associated with liver graft failure: the concept of a donor risk index.

Authors:  S Feng; N P Goodrich; J L Bragg-Gresham; D M Dykstra; J D Punch; M A DebRoy; S M Greenstein; R M Merion
Journal:  Am J Transplant       Date:  2006-04       Impact factor: 8.086

8.  D-MELD, a simple predictor of post liver transplant mortality for optimization of donor/recipient matching.

Authors:  J B Halldorson; R Bakthavatsalam; O Fix; J D Reyes; J D Perkins
Journal:  Am J Transplant       Date:  2008-12-15       Impact factor: 8.086

9.  No country for old livers? Examining and optimizing the utilization of elderly liver grafts.

Authors:  K J Halazun; A A Rana; B Fortune; R C Quillin; E C Verna; B Samstein; J V Guarrera; T Kato; A D Griesemer; A Fox; R S Brown; J C Emond
Journal:  Am J Transplant       Date:  2017-11-08       Impact factor: 8.086

10.  Pretransplant model to predict posttransplant survival in liver transplant patients.

Authors:  Rafik M Ghobrial; Jeffery Gornbein; Randy Steadman; Natale Danino; James F Markmann; Curtis Holt; Dean Anselmo; Farin Amersi; Pauline Chen; Douglas G Farmer; Steve Han; Francisco Derazo; Sammy Saab; Leonard I Goldstein; Sue V McDiarmid; Ronald W Busuttil
Journal:  Ann Surg       Date:  2002-09       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.